Oncology

Mosaic pattern collage
Biotech

Mosaic licenses 2 clinical stage tumor drugs from Otsuka's Astex

Mosaic secured the latest pieces in its medicine combination strategy by licensing two clinical stage tumor drugs from fellow British biotech Astex
James Waldron Apr 24, 2025 10:00am
cellos without players

Bayer boosts precision oncology efforts with multiyear AI deal

Apr 23, 2025 12:55pm
medical data concept with hospital in the background

Tempus AI in line for $200M from AstraZeneca cancer model deal

Apr 23, 2025 9:01am
Glowing puzzle piece fitting into puzzle

Boehringer slots synthetic lethal program into oncology pipeline

Apr 23, 2025 7:45am
reducing people on team

Tempest lays off 80% of workforce to ride out cash crunch

Apr 21, 2025 8:20am
people connecting to others

Flatiron Health, Massive Bio forge patient recruitment pact

Apr 9, 2025 12:47pm
More News

ADCs to cell therapy: How AZ aims to 'redefine' oncology

Apr 9, 2025 11:44am

UK's Epsilogen acquires fellow immunoglobin biotech TigaTx

Apr 7, 2025 8:49am

BioNTech backing powers DualityBio toward $200M Hong Kong IPO

Apr 7, 2025 8:21am

Cyclacel sheds clinical asset in effort to stop cash spiral

Apr 2, 2025 6:01pm